反応 #91237

ord-72921df02ae8479cac77c293b9926cd4

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他obtained in Preparation Example 56
  2. 2
    その他to react sequentially in the same manner as in Steps A and B of Example 1

実験手順

3-Chloromethyl-2-cyclopentylsulfanyl-pyridine (11 mg, 0.05 mmol) obtained in Step C of Preparation Example 8 and ((S)-6-hydroxy-2,3-dihydro-benzofuran-3-yl)-acetic acid methyl ester (10 mg, 0.05 mmol) obtained in Preparation Example 56 were used to react sequentially in the same manner as in Steps A and B of Example 1 to obtain the title compound (13 mg, 70%).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US09447044B2uspto-grants-2016_09